Chaired by Prof. Andrea Necchi, this symposium presented by Prof. Rouprêt and Prof. Retz explores the treatment landscape for muscle-invasive urothelial carcinoma, as well as their perspectives on future treatment landscape. The faculty discuss opportunities for immuno-oncology use in perioperative settings, and optimisation of patient treatment. This symposium also features a panel discussion where the faculty discuss case studies and answer questions directly from the live audience.
This content was funded by Bristol Myers Squibb.
